QIAGEN NV's ticker is and the CUSIP is N72482AB3. A total of 13 filers reported holding QIAGEN NV in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $28,668,000 | +296.3% | 23,000,000 | +283.3% | 0.00% | +300.0% |
| Q3 2019 | $7,234,000 | -17.1% | 6,000,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $8,723,000 | -0.9% | 6,000,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $8,802,000 | +247.9% | 6,000,000 | +200.0% | 0.00% | – |
| Q4 2018 | $2,530,000 | – | 2,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXANE DERIVATIVES | 4 | $1,466,150,000 | 0.42% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 1,800,000 | $3,239,000 | 0.02% |
| AMUNDI ASSET MANAGEMENT US, INC. | 1,600,000 | $2,954,000 | 0.00% |
| BARCLAYS PLC | 1,000,000 | $1,823,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 128,000 | $236,000 | 0.00% |
| CREDIT SUISSE AG/ | 400,000 | $738,000 | 0.00% |
| JPMORGAN CHASE & CO | 1,400,000 | $2,551,000 | 0.00% |